Grant: UNIVERSITY OF TEXAS SOUTHWESTERN MEDICAL CENTER AT DALLAS
Primary Recipient
UNIVERSITY OF TEXAS SOUTHWESTERN MEDICAL CENTER AT DALLAS
Amount
$3,750,000.00
Award Date
9/29/2009
Administering Agency
Health and Human Services, Department of / National Institutes of Health
CDFA Number
93.701
CDFA Program Title
Trans-NIH Recovery Act Research Support
Description
The purpose of this project is to discover new therapeutic targets and drug leads for treating lung cancer. To do this, we have completed an analysis of 56 lung cancer cell lines and have assigned them to 6 genetically distinct clades. Two representativ
Vendors Connected to Award
| Vendor | Role | Amount |
|---|---|---|
| VWR INTERNATIONAL INC | Primary vendor | $29,691.18 |
| MTX CORPORATION | Primary vendor | $26,294.89 |
| INVITROGEN CORP | Primary vendor | $45,345.40 |
| FISHER SCIENTIFIC | Primary vendor | $55,369.70 |
| FISHER SCIENTIFIC | Primary vendor | $89,751.10 |
| DHARMACON INC | Primary vendor | $74,059.15 |
| DHARMACON INC | Primary vendor | $25,731.47 |
| DHARMACON INC | Primary vendor | $88,345.57 |
| BECKMAN COULTER INC | Primary vendor | $72,737.70 |
| APPLIED BIOSYSTEMS | Primary vendor | $94,500.00 |
| FISHER SCIENTIFIC | Primary vendor | $31,674.10 |